Carmell raises $3.0M in private placement of 1.33M shares at $2.25-$2.88

Longevity Health Holdings, Inc.

Gross proceeds ~$3.0M before fees; 1,331,452 shares sold at $2.25 per share to investors and $2.88 to CEO.
CEO participation at $2.88/share equal to April 3 closing price on Nasdaq.
Proceeds for general corporate purposes; officers/directors subject to 90-day lock-up.
Registration rights agreement to be filed within 30 days of closing covering resale of shares.
Post-closing shares outstanding expected to be ~20.58 million.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Longevity Health Holdings, Inc. entered into Purchase Agreement with certain investors named therein (the "Purchasers") valued at approximately $3.0 million (effective 2024-04-04).

Action: entry
Agreement: equity purchase
Counterparty: certain investors named therein (the "Purchasers")
Value: approximately $3.0 million
Effective: 2024-04-04

Exact text from the filing

On April 4, 2024, Carmell Corporation, a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors named therein (the “Purchasers”) for the sale of an aggregate of 1,331,452 shares of the Company’s common stock, $0.0001 par value per share (“Common Stock”), at a price of $2.25 per share for unaffiliated investors and at a price of $2.88 per share for the Company’s Chief Executive Officer (the “Private Placement”).

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

Longevity Health Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-041908

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.